Here, we rigorously assess, synthesize and integrate current knowledge on the structure, regulation and effects of myonectin on metabolic outcomes relevant to the pathophysiology of obesity, MS, and T2D, through a systematic review of molecular, cellular, animal, and human studies. The gene discussed is ERFE; the disease is myeloid sarcoma.